CFKS ESTABLISHES A NEW GLOBAL BENCHMARK FOR BIOLOGICAL PURITY WITH THE LAUNCH OF THE BIO-PURE SERIES

CFKS Sealing Solutions today announces the global launch of the Bio-Pure Series — a comprehensively re-engineered platform of ultra-hygienic industrial sealing systems developed from first principles for the biological purity requirements of aseptic food and beverage processing, dairy manufacturing, pharmaceutical drug production, and bioreactor process environments where microbial contamination of any product stream is not a quality deviation to be managed but a public health event to be prevented absolutely. In an industry where a single contamination incident can trigger the recall of millions of product units, expose consumers to life-threatening bacterial pathogens, generate regulatory enforcement actions across multiple jurisdictions simultaneously, and inflict permanent reputational damage on brands built over decades — the sealing elements at every process pipeline interface, valve seat, pump housing, and vessel connection are not peripheral mechanical components. They are biological safety elements whose design, material formulation, and compliance certification directly determine whether a manufacturing facility’s promise of product purity is kept or broken at the production line. CFKS’s Bio-Pure Series delivers the sanitary engineering architecture, elastomeric material performance, and regulatory compliance documentation that food and pharmaceutical manufacturing operations require to ensure that their sealing infrastructure is never the source of the contamination event they cannot afford to experience.

---

THE CONTAMINATION PROBLEM THAT CONVENTIONAL INDUSTRIAL SEALS CANNOT SOLVE

The global food and pharmaceutical industries have made extraordinary investments in contamination prevention infrastructure — in cleanroom environments, validated sterilization systems, personnel hygiene protocols, and comprehensive microbiological monitoring programs. Yet contamination incidents in food and pharmaceutical manufacturing continue to occur — and when forensic investigations trace contamination events to their physical origin, process equipment interfaces equipped with conventional industrial sealing elements appear with troubling frequency as the primary or contributing contamination source.

The engineering reason for this failure pattern is specific, well-characterized, and directly addressable: conventional industrial seals are not designed with biological contamination prevention as a primary engineering objective. They are designed for mechanical performance — fluid retention, pressure resistance, and dimensional durability — in operating environments where the presence of microbial life within the seal geometry is not a relevant design consideration.

The Crevice Problem: Where Conventional Seals Harbor Life

The sealing geometries of standard industrial O-rings, gaskets, and mechanical seals inevitably create microscopic interstitial spaces — crevices, undercuts, surface irregularities, and dead zones — at the interfaces between the seal element, the process wetted surfaces, and the equipment housing. In industrial applications where process fluid sterility is not required, these crevice geometries are mechanically inconsequential. In food and pharmaceutical applications, they are catastrophic: crevice geometries provide exactly the protected micro-environment that pathogenic microorganisms require to establish and maintain colonization. The physical shelter from turbulent flow within the crevice prevents cleaning agents from achieving the contact time and mechanical action needed for microbial kill during cleaning cycles. The nutrients available in residual process fluid within the crevice provide the metabolic substrate for sustained biofilm development. The result is a protected microbial reservoir within the process equipment — a reservoir that continuously re-inoculates the process stream with pathogenic bacteria across production runs, cleaning cycles, and sterilization procedures that fail to disrupt the biofilm structure.

The pathogens most frequently associated with seal-originating contamination events in food and pharmaceutical manufacturing — Listeria monocytogenes, Salmonella spp., Staphylococcus aureus, Pseudomonas aeruginosa, and Bacillus cereus — share a common characteristic: they are capable of forming highly resistant biofilms on polymeric surfaces within the temperature, pH, and nutrient conditions present in process equipment crevice geometries. Listeria monocytogenes in particular is documented to form biofilms in food processing equipment crevices that resist standard Clean-In-Place concentrations and contact times — a biological fact that makes crevice-free seal design not a quality preference but a microbial control necessity.

The Degradation Problem: How Standard Seals Release Contamination Into the Product Stream

Beyond the microbial harboring risk, conventional industrial elastomeric seal compounds present a second category of contamination risk in food and pharmaceutical applications: chemical and physical degradation of the seal material itself under the aggressive cleaning and sterilization conditions that hygienic manufacturing requires.

Clean-In-Place (CIP) protocols in dairy and food processing operations routinely employ sodium hydroxide (NaOH) concentrations of 1–4% at temperatures of 70–85°C, followed by nitric acid (HNO₃) or phosphoric acid (H₃PO₄) rinses, with total daily exposure times of 30 to 90 minutes per cleaning cycle. Sterilize-In-Place (SIP) protocols add high-temperature steam sterilization at 121–134°C for validated contact times. Over the cumulative chemical and thermal exposure of an annual production calendar, seal compounds that are not specifically formulated for these conditions experience progressive degradation — swelling, surface erosion, hardness change, and microparticle generation — that introduces elastomeric fragments and extractable chemical species into the product stream. In pharmaceutical manufacturing, extractables from degrading elastomeric seal compounds represent a potential drug product contamination pathway that regulatory frameworks including FDA 21 CFR Part 211 and EU GMP Annex 1 address directly — requiring validated demonstration that process contact elastomers do not contribute extractable or leachable species to drug products above defined safety limits.

CFKS’s Bio-Pure Series was developed to address both of these contamination mechanisms — microbial harboring through crevice-free design geometry, and elastomeric degradation through advanced hygienic elastomer compound selection — within a single, fully compliant sanitary sealing platform.

---

THE BIO-PURE SERIES: SANITARY ENGINEERING FROM FIRST PRINCIPLES

Crevice-Free Smooth-Bore Geometry: Eliminating Every Bacterial Trap

The foundational design principle of the Bio-Pure Series is the complete elimination of crevice geometries from every wetted surface of the seal element. This is not achieved through conventional seal design approaches adapted for hygienic applications — it requires a clean-sheet engineering approach in which the sealing function, dimensional geometry, and surface continuity of the seal are designed simultaneously with biological contamination prevention as the primary constraint, and mechanical performance as a co-equal requirement.

Bio-Pure Series seal elements are manufactured to a smooth-bore, crevice-free profile — a geometry in which the product-wetted surface of the seal presents a continuous, smooth, convex or flush profile at every interface with the mating process equipment surfaces, with no undercuts, no corners below 3mm radius, no surface roughness above Ra 0.8 μm, and no interstitial voids at the seal-to-housing interface that are inaccessible to cleaning flow.

The geometric design of every Bio-Pure seal profile is validated against the EHEDG (European Hygienic Engineering and Design Group) guideline document EL Class I — the most stringent international standard for hygienic equipment design, which defines specific geometric criteria for cleanable equipment surfaces. CFKS’s engineering team conducts hygienic design review of every Bio-Pure seal geometry using computational fluid dynamics modeling of cleaning flow at the seal interface — verifying that the cleaning agent velocity, contact time, and turbulence at every surface point of the installed seal meet the EHEDG criteria for complete microbial removal during standard CIP protocols before the geometry is released to production.

The physical consequence of this crevice-free geometric discipline is direct and validated: in EHEDG-certified cleanability testing, Bio-Pure Series seals demonstrate complete removal of Enterococcus faecium (EHEDG standard challenge organism) from all wetted surfaces within a single standard CIP cycle — a performance that conventional industrial seals with crevice geometries consistently fail to achieve under identical test conditions.

Surface Finish Engineering: The Ra 0.8 μm Standard and Beyond

Beyond macro-scale crevice elimination, the Bio-Pure Series addresses microbial contamination risk at the surface roughness scale through precision surface finish manufacturing protocols that achieve and consistently maintain product-contact surface roughness values at or below Ra 0.8 μm — the threshold below which biofilm formation rates on elastomeric surfaces are demonstrably reduced in peer-reviewed microbiological research.

Bio-Pure elastomeric seal elements are precision-molded using CFKS’s hygienic tooling program — mold surfaces maintained to the same Ra 0.8 μm surface finish standard as the target part specification, ensuring that molded part surface quality is defined by the tooling geometry rather than limited by post-molding surface treatment. Every production lot undergoes profilometric surface measurement with statistical sampling to verify that the Ra specification is maintained across the production population.

---

ADVANCED HYGIENIC ELASTOMER COMPOUNDS: THE MATERIAL SCIENCE OF BIOLOGICAL PURITY

Food-Grade EPDM (Bio-Pure FE Grade) — The Dairy and Beverage Standard

CFKS’s Bio-Pure FE grade is formulated from an FDA 21 CFR 177.2600-compliant EPDM (ethylene propylene diene monomer) compound — the benchmark elastomer for dairy processing, beverage manufacturing, and aqueous food process applications:

• Operating temperature range: -40°C to +150°C, encompassing the full thermal range of CIP and SIP protocols in food processing
• Chemical resistance: Excellent resistance to steam, hot water, sodium hydroxide and nitric acid CIP chemistries at standard food processing concentrations, and to the enzymatic cleaning agents increasingly specified in low-temperature CIP programs
• Compliance: FDA 21 CFR 177.2600 (food contact rubber), EC 1935/2004 (European food contact materials regulation), USP Class VI (pharmaceutical biocompatibility)
• Extractables profile: Validated low-extractables formulation with documented extraction testing per USP <661> methodology — providing pharmaceutical and premium food customers with the extractables data required for regulatory submission support
• CIP/SIP durability: Validated resistance to 2,000 cumulative CIP cycles at standard dairy processing conditions (2% NaOH, 75°C, 30 minutes per cycle) without measurable change in hardness, tensile strength, or compression set — the material durability performance that food processing facilities require to establish validated seal replacement intervals

Pharmaceutical-Grade FKM (Bio-Pure PF Grade) — The Pharmaceutical and Chemical Process Standard

For pharmaceutical manufacturing environments — drug substance reactors, formulation processing, sterile fill-finish operations — and food processing applications involving aggressive cleaning chemistries, solvents, or high-temperature oxidizing sterilants, CFKS’s Bio-Pure PF grade provides the enhanced chemical resistance of a pharmaceutical-grade fluorocarbon elastomer:

• Operating temperature range: -20°C to +200°C, validated for steam sterilization and aggressive chemical sterilant exposure
• Chemical resistance: Exceptional resistance to concentrated cleaning acids, oxidizing sterilants including hydrogen peroxide (H₂O₂) vapor sterilization systems used in isolator and aseptic filling environments, and the broad range of organic solvents and process chemistries encountered in pharmaceutical drug substance synthesis and formulation
• Compliance: USP Class VI biocompatibility, FDA 21 CFR 177.2600, EC 1935/2004, and 3-A Sanitary Standards compliance — encompassing the full regulatory framework applicable to pharmaceutical and food process contact elastomers across global markets
• Extractables and leachables: Comprehensive extractables characterization under ISO 10993-12 extraction conditions, providing the dataset required for leachables risk assessment per ICH Q3D and EMEA/CHMP/CVMP/SWP guidelines

Food-Grade Silicone (Bio-Pure FS Grade) — The High-Temperature and Transparency-Critical Standard

For applications requiring high-temperature performance in combination with transparency for process monitoring, or biocompatibility requirements for direct pharmaceutical product contact in fill-finish operations:

• Operating temperature range: -60°C to +200°C
• Compliance: FDA 21 CFR 177.2600, USP Class VI, ISO 10993 biocompatibility series
• Platinum cure system: Bio-Pure FS grade employs an exclusively platinum-catalyzed cure system, eliminating the peroxide-derived organic byproducts present in peroxide-cured silicone compounds that generate extractable species of regulatory concern in pharmaceutical product contact applications

---

CIP/SIP PERFORMANCE VALIDATION: SEAL INTEGRITY UNDER CHEMICAL ASSAULT

The compliance claims of the Bio-Pure Series are supported by a comprehensive validation testing program that subjects seal assemblies to cleaning and sterilization conditions that replicate — or exceed — the most aggressive CIP and SIP protocols employed in food and pharmaceutical manufacturing operations:

CIP Chemical Resistance Protocol: Bio-Pure seal assemblies are subjected to cyclic immersion testing encompassing alternating sodium hydroxide (2–4% NaOH, 80°C), nitric acid (1–2% HNO₃, 70°C), and ultra-pure water rinse cycles — with post-cycle dimensional, hardness, and mass measurement to quantify compound stability across 2,000 cumulative cleaning cycles. All three Bio-Pure compound grades demonstrate dimensional stability within ±2% of baseline values across the full 2,000-cycle test program — providing documented evidence for the extended replacement interval validation that food processing quality management systems require.

SIP Steam Sterilization Protocol: Bio-Pure seal assemblies are subjected to saturated steam sterilization at 134°C for 60-minute cumulative exposure periods — exceeding the standard F₀ 15 sterilization specification for pharmaceutical steam sterilization — with post-sterilization compression set, tensile, and sealing performance measurement. Bio-Pure FE and PF grades maintain sealing integrity and dimensional stability within validated limits across all steam sterilization test cycles.

Extractables Testing: Bio-Pure compound grades undergo extractables characterization under three extraction conditions — 121°C autoclave extraction in water, 50°C extraction in simulated product media, and 40°C extraction in 50% ethanol/water — with extract analysis by ICP-MS (inorganic species), GC-MS (organic species), and HPLC (involatile organic species) to provide a comprehensive extractables profile for regulatory submission support documentation.

---

REGULATORY COMPLIANCE ARCHITECTURE: THE FULL CERTIFICATION FRAMEWORK

The Bio-Pure Series is supported by a regulatory compliance architecture that encompasses the complete framework of international food and pharmaceutical manufacturing regulations:

FDA 21 CFR 177.2600: All Bio-Pure elastomeric compounds are formulated from ingredients permitted under FDA 21 CFR 177.2600 (rubber articles intended for repeated use in contact with food) — providing the regulatory basis for food contact approval in United States and FDA-aligned global markets.

EHEDG EL Class I Certification: Bio-Pure Series seal profiles achieving EHEDG EL Class I certification provide customers with the independent third-party hygienic design validation that European food authority inspectors and EHEDG-committed food processing companies specify.

3-A Sanitary Standards: Bio-Pure elastomeric compounds and seal geometries comply with 3-A Sanitary Standards for multiple dairy and food equipment categories — encompassing the leading sanitary equipment standard in North American dairy and beverage manufacturing.

USP Class VI: Bio-Pure FE, PF, and FS grades carry USP Class VI biocompatibility designation — the biological safety testing standard required for elastomeric materials in direct pharmaceutical product contact applications in the United States and internationally harmonized regulatory frameworks.

EU GMP Annex 1 Alignment: For pharmaceutical customers subject to the revised EU GMP Annex 1 (2023) requirements for contamination control strategy in sterile medicinal product manufacturing, CFKS provides technical documentation supporting Bio-Pure Series specification within validated contamination control strategy frameworks — including material qualification documentation, extractables data, and hygienic design validation to support regulatory submission.

---

EXECUTIVE QUOTE

“In food and pharmaceutical manufacturing, every contamination incident that reaches a consumer or a patient is a failure that occurred somewhere in the physical infrastructure of the production process — not in an executive’s quality commitment or in a regulatory submission, but at a specific surface, in a specific piece of equipment, where a biological hazard was allowed to exist. When contamination investigators trace those failures to seal crevice geometry, to elastomer degradation, or to non-hygienic design of process equipment interfaces, they are describing an engineering problem with an engineering solution. The Bio-Pure Series is CFKS’s engineering solution. We have eliminated the crevice geometries that harbor biofilm, specified the elastomeric compounds that survive the cleaning protocols that kill bacteria, and validated both through the independent certification frameworks that regulators and food safety authorities recognize. Our commitment is simple and non-negotiable: no seal that carries the CFKS Bio-Pure designation will ever be the source of the contamination event that harms a consumer or destroys a product batch. That standard does not have exceptions for low-risk applications or cost-sensitive procurement decisions. It is the baseline from which we will not depart.”

— Head of Quality and Compliance / CEO, CFKS Sealing Solutions

---

ABOUT CFKS

CFKS Sealing Solutions is a precision engineering company and globally active manufacturer of high-performance sealing systems, serving the food and beverage processing, dairy manufacturing, pharmaceutical drug production, biotechnology, and chemical process industries. The company’s Bio-Pure division represents CFKS’s dedicated engineering and manufacturing capability for health-critical and contamination-sensitive sealing applications — combining advanced hygienic design engineering, regulatory-grade elastomeric material science, and comprehensive compliance certification to provide food and pharmaceutical manufacturing operations with sealing solutions that meet the biological purity requirements of the world’s most stringent product safety standards. CFKS serves QA directors, process engineers, and plant managers at leading global food corporations, dairy companies, pharmaceutical manufacturers, and biotechnology facilities across Europe, North America, the Middle East, Southeast Asia, and Asia-Pacific — with a consistent commitment to providing sealing infrastructure that supports rather than compromises the product purity and consumer safety promises that these organizations make to the public.